Astex Pharmaceutical takes another leg higher on positive Phase II trial results for SGI-110

|About: Astex Pharmaceuticals, Inc. (ASTX)|By:, SA News Editor

Astex Pharmaceutical (ASTX) continues to run, now up more than 23% following positive topline results from Phase II trials of its SGI-110 drug candidate in patients with acute myelogenous leukemia and myelodysplastic syndromes.